Profound Medical Corp's stock has seen a notable uptick, closing up 2.36% in the last trading session.
In a positive turn for investors, Profound Medical Corp (PRN.TO) experienced a rise in its stock price, closing at CA$9.98. This increase reflects growing investor confidence in the company's recent performance and strategic initiatives.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
Profound Medical Corp
PRN.TO
PRN.TO
Profound Medical Corp
WealthAwesomeMarket cap
$348.84M
52W high
$12.40
52W low
$5.23
1W change
-5.51%
Beta
0.53
Analyst Price Targets
Based on analyst covering PRN
Wall Street analysts forecast PRN stock price to rise 160.7% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$25.03
+160.7% Upside
Current Price
C$9.60
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on PRN's historical volatility
30-Day Vol
40.5%
Annualized
90-Day Vol
57.4%
Annualized
Trend (90d)
+11.5%
Annualized drift
90d Mean
C$10.00
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$9.73 | C$8.46 – C$11.19 |
| 60 trading days | C$9.87 | C$8.10 – C$12.03 |
| 90 trading days | C$10.00 | C$7.85 – C$12.75 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Profound Medical's recent financial results and strategic moves signal a promising outlook, making it a stock to watch for potential growth.
Profound Medical Corp sees a 2.36% rise in stock price
The stock closed at CA$9.98, reflecting a market cap of approximately CA$354 million.
Bull case
The company reported a remarkable 104% revenue growth in Q1 2026, along with expanded coverage for the TULSA Procedure™ by Humana. These developments are attracting investor interest and strengthening the company's growth narrative.
Bear case
However, despite the positive momentum, Profound Medical still faces challenges with profitability and ongoing financial issues, which could pose risks for investors in the long run.
Recent Performance Highlights
Profound Medical Corp's stock increased by 2.36% in the last session, closing at CA$9.98. This rise comes on the heels of impressive financial results, including a 104% revenue growth reported for Q1 2026. Such performance shows the company's expanding market presence and operational improvements.
Strategic Developments
The recent upsize of a private placement to raise up to US$6.45 million has also contributed to investor optimism. By issuing common shares at US$7.00 each, Profound Medical is positioning itself for further growth and development in its innovative medical solutions.
Looking Ahead
As Profound Medical continues to enhance its offerings and expand its market reach, investors will be keenly watching for further updates on financial performance and strategic initiatives. The company’s ability to maintain this momentum will be crucial in determining its future stock performance.
Advertisement
